1            Broadly neutralizing antibodies (bNAbs) to HIV-1 can prevent infection and are therefore of great importance f

2   Passive transfer of neutralizing antibodies against HIV-1 can prevent infection in macaques and seems to delay HIV-1 re

3 ls have shown that broadly neutralizing antibodies to HIV-1 can prevent infection, suggesting that a vaccine that elicits

4                                                Although Abs can prevent infection, disease and death can be prevented by

5     Passive transfer of broadly neutralizing HIV antibodies can prevent infection, which suggests that vaccines that elic

6                                            These antibodies can prevent infection and suppress viraemia in humanized mice

7                  When administered passively, this antibody can prevent infection in animal models and suppress viremia i

8 s (Osps) A, B, and C of the spirochete Borrelia burgdorferi can prevent infection in animal models of Lyme borreliosis.

9 t for understanding gut health as non-diarrheagenic E. coli can prevent infection by diarrheagenic bacteria.

10 that sufficient levels of neutralizing antibody against HIV can prevent infection, although the effect is type-specific.

11  hours of a percutaneous or mucous membrane exposure to HIV can prevent infection.

12 dely used statin, which is generally considered to be safe, can prevent infection or minimize its severity, inhibition of

13          Thus, DH1047 is a broadly protective antibody that can prevent infection and mitigate outbreaks caused by SARS-r

14 HIV-1 develops broadly neutralizing antibodies (bNAbs) that can prevent infection, but it has not yet been possible to el

15        Therefore, it is important to develop a vaccine that can prevent infection by both lethal species.

16  the field of AIDS research, an effective AIDS vaccine that can prevent infection remains elusive.

17                           Seasonal influenza virus vaccines can prevent infection, but are rendered ineffective by antige